InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Pauls Dietrich John, Chairman & CEO. Insider active across 1 companies, notably DiaMedica Therapeutics Inc.. Cumulatively, 2 filings have been published. Total volume traded: €27k. The latest transaction was disclosed on 16 August 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€13,3285,000 shares@ €2.6655100.0% of flow
Voting Common Shares, no par value per share
SEC:0001235802-21-000098·
Ideal exit: 13 May 2022 (T+270)
€13,3285,000 shares@ €2.66550.0032% mcap50.0% of flow
Voting Common Shares, no par value per share
SEC:0001235802-21-000098:0·
Ideal exit: 13 May 2022 (T+270)
2 of 2 declarations
About Pauls Dietrich John
John Pauls is the President and CEO of DiaMedica Therapeutics Inc., a biopharmaceutical company. In his role, he is responsible for the strategic direction of the company and the management of its operations. With experience in the biopharmaceutical sector, he plays a key role in developing new treatments and driving innovation.
